| Autor: |
Jermilia, Charles, Victoria A, Ploplis |
| Rok vydání: |
2022 |
| Předmět: |
|
| Zdroj: |
Current Drug Targets. 23:1603-1610 |
| ISSN: |
1389-4501 |
| Popis: |
Background: Infection with SARS-CoV-2 leads to COVID-19 which can manifest in various ways from asymptomatic or mild disease to acute respiratory distress syndrome. The occur-rence of dysregulated inflammatory responses in the form of a cytokine storm has been reported in patients with severe COVID-19. Infection can also lead to dysfunctional hemostasis reflected in el-evated circulating D-dimer and fibrin degradation products. Components of hemostasis and the im-mune system during infection can result in a procoagulation and/or proinflammatory state. The in-terplay between coagulation and inflammation has been elucidated in a number of diseases. Objective: In this article, we discuss the occurrence of cytokine storms and dysfunctional hemosta-sis induced in COVID-19. Methods: This review was written using literature from the past two to three years investigating co-agulation and inflammation in COVID-19. Additional literature, both clinical and basic research, related to pathogen infection and host responses were also considered in this review. Results/Conclusions: Infection with SARS-CoV-2 can lead to dysregulated inflammatory respons-es that may be detrimental to the host. The increased expression of various inflammatory factors can ultimately create an environment that promotes thrombosis. |
| Databáze: |
OpenAIRE |
| Externí odkaz: |
|
